Heron Therapeutics Inc (NASDAQ:HRTX)

30.20
Delayed Data
As of Jul 02
 -0.65 / -2.11%
Today’s Change
6.51
Today|||52-Week Range
34.03
+200.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-11.8M-23.3M-55.3M-76.4M
 
 
 
 
 
Depreciation179.0K197.0K333.0K578.0K
 
 
 
 
 
Total Other Cash Flow2.4M5.0M11.4M9.6M
 
 
 
 
 
Funds From Operations-9.3M-18.1M-43.5M-66.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.5M-1.1M-2.8M-5.9M
 
 
 
 
 
Net Cash Flow - Operating Activities-7.7M-17.0M-40.8M-60.3M
 
 
 
 
 
 
InvestingCapital Expenditures-513.0K-972.0K-1.7M-1.4M
 
 
 
 
 
Net Cash Flow Investing-513.0K-972.0K-1.7M-1.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.003.0M0.000.00
 
 
Long Term Borrowings1.3M0.000.000.00
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale22.8M50.5M61.2M62.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing24.1M53.5M61.2M62.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash15.9M35.5M18.8M388.0K
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account